We have located links that may give you full text access.
Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography.
European Journal of Radiology 2020 November
PURPOSE: To examine the frequency and patterns of renal parenchymal retention of iodinated contrast agent during follow-up computed tomography (CT) performed one day after undergoing contrast-enhanced CT and to evaluate the association with the renal function before and after contrast-enhanced CT.
MATERIALS AND METHODS: This retrospective study included 55 patients who underwent follow-up CT the day after contrast-enhanced CT had been performed. Two radiologists categorized the retention patterns on a scale of 0-6 (0: no retention, 1: diffuse parenchymal, 2: diffuse cortical, 3: subcapsular tiny nodular, 4: cortical wedge-shaped, 5: medullary focal, 6: renal pelvic). In addition, we collected the patients' clinical data, including the development of contrast-induced nephropathy (CIN).
RESULTS: A total of 37 patients (67 %) showed retention of contrast agent in the kidney (retention group), while 18 did not (non-retention group). A diffuse parenchymal pattern and renal pelvis pattern were the most common. High levels of creatinine (Cre) and blood urea nitrogen (BUN) before contrast-enhanced CT were significantly associated with the retention in the kidney (p = 0.018, 0.006, respectively). The frequency of the development of CIN was significantly higher (p = 0.021) in the retention group (10/37) than in the non-retention group (0/18). A diffuse parenchymal pattern and diffuse cortical pattern were significantly more common in patients with CIN than in those without CIN (p = 0.003, p = 0.045, respectively).
CONCLUSION: Renal parenchymal retention of iodinated contrast agent the day after contrast-enhanced CT was a frequently recognized finding and was associated with renal dysfunction. This finding, especially diffuse parenchymal and cortical patterns, may be a potential biomarker of CIN development.
MATERIALS AND METHODS: This retrospective study included 55 patients who underwent follow-up CT the day after contrast-enhanced CT had been performed. Two radiologists categorized the retention patterns on a scale of 0-6 (0: no retention, 1: diffuse parenchymal, 2: diffuse cortical, 3: subcapsular tiny nodular, 4: cortical wedge-shaped, 5: medullary focal, 6: renal pelvic). In addition, we collected the patients' clinical data, including the development of contrast-induced nephropathy (CIN).
RESULTS: A total of 37 patients (67 %) showed retention of contrast agent in the kidney (retention group), while 18 did not (non-retention group). A diffuse parenchymal pattern and renal pelvis pattern were the most common. High levels of creatinine (Cre) and blood urea nitrogen (BUN) before contrast-enhanced CT were significantly associated with the retention in the kidney (p = 0.018, 0.006, respectively). The frequency of the development of CIN was significantly higher (p = 0.021) in the retention group (10/37) than in the non-retention group (0/18). A diffuse parenchymal pattern and diffuse cortical pattern were significantly more common in patients with CIN than in those without CIN (p = 0.003, p = 0.045, respectively).
CONCLUSION: Renal parenchymal retention of iodinated contrast agent the day after contrast-enhanced CT was a frequently recognized finding and was associated with renal dysfunction. This finding, especially diffuse parenchymal and cortical patterns, may be a potential biomarker of CIN development.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app